Skip to main content

Leukemia, lymphoma, and myeloma.

265 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Leukemia, lymphoma, and myeloma265 studies

Hairy Cell LeukemiaPhase 1NCT04815356Papers

CD22CART cell

Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant

National Cancer Institute (NCI)Open the brief

Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic SyndromePhase 1NCT05986240

Danvatirsen

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Montefiore Medical CenterOpen the brief

Clinical trials: Phase 1 and Phase 2, explained